Geneos Wealth Management’s Prothena Corp PRTA Stock Holding History

Geneos Wealth Management’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-26	Closed	–	–	2453
2022 Q2	$0	Hold	26	–	–	﹤0.01%	2741
2022 Q1	$0	Hold	26	–	–	﹤0.01%	2928
2021 Q4	$1K	Hold	26	–	–	﹤0.01%	2702
2021 Q3	$1K	Hold	26	–	–	﹤0.01%	2774
2021 Q2	$1K	Buy	+26	New	+$811	﹤0.01%	2785
2018 Q3	–	Sell	-79	Closed	-$1K	–	2443
2018 Q2	$1K	Sell	79 -4	-5%	-$79	﹤0.01%	2213
2018 Q1	$3K	Hold	83	–	–	﹤0.01%	1966
2017 Q4	$3K	Buy	83 +2	+2%	+$102	﹤0.01%	1954
2017 Q3	$5K	Sell	81 -36	-31%	-$2.21K	﹤0.01%	1764
2017 Q2	$6K	Hold	117	–	–	﹤0.01%	1685
2017 Q1	$6K	Hold	117	–	–	﹤0.01%	1651
2016 Q4	$5K	Sell	117 -28	-19%	-$1.54K	﹤0.01%	1637
2016 Q3	$8K	Hold	145	–	–	﹤0.01%	1451
2016 Q2	$5K	Sell	145 -14	-9%	-$610	﹤0.01%	1529
2016 Q1	$6K	Buy	+159	New	+$6.22K	﹤0.01%	1448

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geneos Wealth Management's PRTA Position: Q3 2022 in Review

Geneos Wealth Management sold out of Prothena Corp (PRTA) in Q3 2022, closing a stake of 26 shares.

Geneos Wealth Management first reported a position in PRTA in Q1 2016 and held it in 15 quarters. The position peaked at $8K in Q3 2016. 183 funds tracked by Wall St. Rank hold PRTA as of Q3 2022.

Geneos Wealth Management reported no remaining Prothena Corp position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 26 Prothena Corp shares in Q3 2022.
Geneos Wealth Management first reported a position in Prothena Corp in Q1 2016 and held it in 15 quarters.
Geneos Wealth Management's Prothena Corp position peaked at $8K in Q3 2016.
183 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.